Skip to content

ARA-290: Benefits & Research

Part of the ARA-290 Complete Guide

Partner

Research Peptides

BioLongevity Labs15% Off
Shop Peptides at BioLongevity Labs

We may earn a commission if you purchase through this link, at no extra cost to you.

Neuropathic Pain Relief

Phase 2 trials demonstrated ARA-290 improved neuropathic pain scores and increased small fiber nerve density in patients with sarcoidosis-associated neuropathy. Corneal confocal microscopy showed measurable nerve fiber regeneration — objective evidence of structural nerve repair.

Tissue-Protective Effects

ARA-290 activates the innate repair receptor (IRR), triggering anti-apoptotic and anti-inflammatory cascades. The IRR is expressed on stressed and damaged cells, making ARA-290's effects selectively targeted to injured tissue rather than healthy cells.

Metabolic Improvements

Studies in type 2 diabetes patients showed ARA-290 improved metabolic control alongside neuropathic symptom relief. The EPO-derived pathway has established connections to metabolic regulation beyond erythropoiesis.

Frequently Asked Questions

References

  1. Brines M, et al.. ARA 290 improves metabolic control and neuropathic symptoms in patients with type 2 diabetes. Mol Med, 2015.

Researching peptides? We did the hard part.

Get our free Peptide Starter Kit — the 5 most researched compounds, simplified into one actionable guide.

Related Guides

PI

Peptides Insider Editorial Team

Our content is reviewed for accuracy and grounded in peer-reviewed research where available. We do not provide medical advice. Always consult a qualified healthcare professional.